Antibiotic dosing: do we dose to cure the individual or do we treat the greater societal needs?

Author： Blondeau Joseph M   Tillotson Glenn S  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.2, Iss.4, 2005-07, pp. : 511-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HOW FREQUENTLY DO WE HAVE A CURE WITHOUT DIAGNOSIS? THE INDISPENSABLE CONSULTANT!!!*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 15, Iss. 1, 1967-01 ,pp. : 65-67

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat, how shall we treat? A review of the literature

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1503-1509

John Wiley & Sons Inc

Access to resources Recommend Favorite

pO2 – Do We Treat the Right Thing?

By  

Respiration, Vol. 70, Iss. 5, 2003-12 ,pp. : 455-456

Karger

Access to resources Recommend Favorite

Antibiotic resistance: what have we learned and where do we go from here?

By Blondeau Joseph  

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 751-753

Future Medicine

Access to resources Recommend Favorite

How do we learn?

By Lasserson Michael  

British Journal of General Practice, Vol. 61, Iss. 584, 2011-03 ,pp. : 232-232

Royal College of General Practitioners

Access to resources Recommend Favorite